Evaluation of deep learning based dose prediction in head and neck cancer patients using two different types of input contours

J Appl Clin Med Phys. 2024 Sep 16:e14519. doi: 10.1002/acm2.14519. Online ahead of print.

Abstract

Purpose: This study evaluates deep learning (DL) based dose prediction methods in head and neck cancer (HNC) patients using two types of input contours.

Materials and methods: Seventy-five HNC patients undergoing two-step volumetric-modulated arc therapy were included. Dose prediction was performed using the AIVOT prototype (AiRato.Inc, Sendai, Japan), a commercial software with an HD U-net-based dose distribution prediction system. Models were developed for the initial plan (46 Gy/23Fr) and boost plan (24 Gy/12Fr), trained with 65 cases and tested with 10 cases. The 8-channel model used one target (PTV) and seven organs at risk (OARs), while the 10-channel model added two dummy contours (PTV ring and spinal cord PRV). Predicted and deliverable doses, obtained through dose mimicking on another radiation treatment planning system, were evaluated using dose-volume indices for PTV and OARs.

Results: For the initial plan, both models achieved approximately 2% prediction accuracy for the target dose and maintained accuracy within 3.2 Gy for OARs. The 10-channel model outperformed the 8-channel model for certain dose indices. For the boost plan, both models exhibited prediction accuracies of approximately 2% for the target dose and 1 Gy for OARs. The 10-channel model showed significantly closer predictions to the ground truth for D50% and Dmean. Deliverable plans based on prediction doses showed little significant difference compared to the ground truth, especially for the boost plan.

Conclusion: DL-based dose prediction using the AIVOT prototype software in HNC patients yielded promising results. While additional contours may enhance prediction accuracy, their impact on dose mimicking is relatively small.

Keywords: deep learning based dose prediction; head and neck cancer; volumetric‐modulated arc therapy.